Nerve Injury - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Nerve Injury - Pipeline Review, H2 2016

Nerve Injury - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Nerve Injury - Pipeline Review, H2 2016
Published Jul 13, 2016
70 pages — Published Jul 13, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Nerve Injury - Pipeline Review, H2 2016, provides an overview of the Nerve Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Nerve Injury and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Nerve Injury
- The report reviews pipeline therapeutics for Nerve Injury by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Nerve Injury therapeutics and enlists all their major and minor projects
- The report assesses Nerve Injury therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Nerve Injury

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Nerve Injury
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Nerve Injury pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing

  
Source:
Document ID
GMDHC8269IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Introduction61
  Global Markets Direct Report Coverage61
Nerve Injury Overview71
Therapeutics Development82
  Pipeline Products for Nerve Injury Overview81
  Pipeline Products for Nerve Injury Comparative Analysis91
Nerve Injury Therapeutics under Development by Companies101
Nerve Injury Therapeutics under Investigation by Universities/Institutes111
Nerve Injury Pipeline Products Glance122
  Clinical Stage Products121
  Early Stage Products131
Nerve Injury Products under Development by Companies141
Nerve Injury Products under Investigation by Universities/Institutes151
Nerve Injury Companies Involved in Therapeutics Development1610
  Biogen, Inc.161
  BrainStorm Cell Therapeutics Inc.171
  Calico LLC181
  F. Hoffmann-La Roche Ltd.191
  Human Stem Cells Institute201
  Medtronic plc211
  Neuralstem, Inc.221
  Neurotune AG231
  SanBio, Inc.241
  TissueGene, Inc.251
Nerve Injury Therapeutics Assessment269
  Assessment by Monotherapy Products261
  Assessment by Target272
  Assessment by Mechanism of Action292
  Assessment by Route of Administration312
  Assessment by Molecule Type332
Drug Profiles3532
  3K3A-APC Drug Profile352
  CLP-257 Drug Profile371
  MDT-15 Drug Profile381
  Neovasculgen Drug Profile391
  NSI-566 Drug Profile408
  NT-1654 Drug Profile481
  raxatrigine hydrochloride Drug Profile493
  SB-618 Drug Profile521
  Small Molecules for Peripheral Nerve Injury Drug Profile531
  Small Molecules to Activate NAMPT for Neurological Disorders Drug Profile541
  Stem Cell Therapy for Neurodegenerative Disorders Drug Profile558
  Synthetic Peptides to Inhibit CaMKII for Stroke and Nerve Injury Drug Profile631
  TG-N Drug Profile641
  U-2902 Drug Profile652
Nerve Injury Dormant Projects671
Nerve Injury Discontinued Products681
Appendix692
  Methodology691
  Coverage691
  Secondary Research691
  Primary Research691
  Expert Panel Validation691
  Contact Us691
  Disclaimer701

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Nerve Injury - Pipeline Review, H2 2016" Jul 13, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Nerve-Injury-Pipeline-Review-H2-2016-2088-16170>
  
APA:
Global Markets Direct - Market Research. (2016). Nerve Injury - Pipeline Review, H2 2016 Jul 13, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Nerve-Injury-Pipeline-Review-H2-2016-2088-16170>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.